Yun Fan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cell death & disease

Thoracic cancer

Molecular cancer therapeutics

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for correlations between metabolites in patients receiving immunotherapy for metastatic or recurrent NSCLC: an exploratory study based on two cohorts. Molecular cancer therapeutics (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Qian Zhang, Kai-Yan Chen, Xiaoqing Yu, Yun Fan
Spotlight on the treatment of non-small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives. International journal of cancer (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Kai-Yan Chen, Yanjun Xu, Zhiyu Huang, Xiaoqing Yu, Wei Hong, Hui Li, Xiaoling Xu, Hongyang Lu, Fajun Xie, Jun Chen, Youzu Xu, Yun Fan
Sintilimab plus anlotinib as second- or third-line therapy in metastatic non-small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single-arm, phase II trial. Cancer medicine (2023)
Wanji Shen, Ying Jin, Ying Yu, Ning Chen, Yun Fan
Small molecule multitarget antiangiogenic inhibitor treatments for advanced thymic epithelial tumors: A retrospective study. Thoracic cancer (2023)
Shun Lu, Jian Fang, Ziping Wang, Yun Fan, Yunpeng Liu, Jian-Xing He, Jian-Ying Zhou, Jie Hu, Jinjing Xia, Wenxin Liu, Jane Shi, Jing Yi, Lejie Cao
Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer. Cancer medicine (2022)
Zi-Chao Zhou, Kai-Yan Chen, Na Li, Ming-Ying Xie, Jia-Min Sheng, Yun Fan, Zhi-Yu Huang
Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer. Thoracic cancer 13 (16) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Na Li, Ming-Ying Xie, Zi-Chao Zhou, Jia-Min Sheng, Xiaoqing Yu, Yun Fan
Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China. Thoracic cancer (2022)
Ying Yu, Kaiyan Chen, Yun Fan
Extensive-stage small-cell lung cancer: Current management and future directions. International journal of cancer (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Jia-Min Sheng, Hui Li, Xiaoqing Yu, Sizhe Yu, Kai-Yan Chen, Guoqiang Pan, Ming-Ying Xie, Na Li, Zi-Chao Zhou, Yun Fan
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China. Thoracic cancer 12 (22) (2021)